OncoHost Company
OncoHost, an Israeli start-up, is developing a platform to help in selecting the most suitable treatment for oncology patients in accordance with their individual characteristics and, through using advanced technologies and machine learning algorithms, to provide a multidimensional analysis of each individual patient’s immune system. The OncoHost platform’s advanced processing tools will enable analysis of the specific impacts of the stay in space on each astronaut’s immune system.
Technology:
Omic
Industry:
Longevity Biomarkers
Headquarters:
Binyamina
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2
Total Funding:
16000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-01-19
Last Funding Type:
Series B
Register and Claim Ownership